EN DE

Harper Hygienics S.A. (HRP) Fair Value & Analysis

Consumer Defensive · PL · Market cap 31.5M PLN (≈ $8.4M) · ISIN PLHRPHG00023

HH Harper Hygienics S.A. HRP · WAR
Price4.97 PLN
Fair Value9.34 PLN
Upside+87.9%
Quality51/100
Watch Harper Hygienics S.A. for free, get notified when fair value or trend changes. Watch for free

Strengths

Trades 47% below our fair value of 9.34 PLN
Moderate debt · generates free cash flow

Risks

!Weak Growth (revenue 5y +1.8 %/yr)
!Loss over the last twelve months · -7.4% net margin · fiscal year 2025 2.9%
!Mixed vs. peers (6/13)
!Narrow moat 23/100
Weak Growth (revenue 5y +1.8 %/yr)
Loss over the last twelve months · -7.4% net margin · fiscal year 2025 2.9%
Moderate debt · generates free cash flow
Mixed vs. peers (6/13)
Narrow moat 23/100
Evidence: High Range 5.91 PLN – 19.69 PLN Share as image

Fair value as of: Aug 20, 2026

From 20 valuation models · updated 10 days ago

Fair value updated Aug 20, 2026, revised from 4.22 PLN to 9.34 PLN (+121.3%) since Aug 13, 2026. Share price −2.9% over the past month.

A solid business, trading 47% below our fair value.

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Track Harper Hygienics S.A. and get told automatically when its fair value or trend turns, plus fair value for all 35,000+ stocks. 14 days of Pro free, no card. Track it free

What matters now

  • The price is below even our cautious bear case (5.91 PLN). The market is more pessimistic than our downside scenario.
  • The model range is unusually wide (5.91 PLN to 19.69 PLN). The outcome hinges heavily on assumptions, so read the point estimate with caution.
  • Solid quality (51/100) at a price below fair value, the discount is the argument here, not the business quality.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

13.45 PLN 4.00 PLN Fair Value 9.34 PLN May 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 20, 2026.

How to read this chart

60‑month range 4.00 PLN – 13.45 PLN · fair‑value band 5.91 PLN – 19.69 PLN · the 4.97 PLN price screens below the 9.34 PLN fair value. Dashed = 300-day average. As of Aug 20, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Harper Hygienics S.A. (HRP) currently trades at 4.97 PLN, while our model-based Fair Value estimate is 9.34 PLN, implying the stock looks roughly 87.9% undervalued today. The Quality Score stands at 51/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.

Over the trailing twelve months, Harper Hygienics S.A. generated revenue of 237M PLN at a net margin of -7.4%. Revenue grew 7.1% year over year. It earns a return on equity of -28.0%. Net debt stands at 81.0M PLN. Fundamentals as of Aug 20, 2026

Our scenario range runs from 5.91 PLN (bear case) to 19.69 PLN (bull case); at 4.97 PLN, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 32% below its 52-week high and 5% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -36% fair-value upside, at 88%, HRP screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Rev-Margin DCF 0.7000 PLN 9.01 PLN 19.14 PLN 74
ROIC Compounder 3.14 PLN 5.04 PLN 6.58 PLN 72
Growth-Adj P/E 12.73 PLN 18.18 PLN 23.64 PLN 68
All 20 models by family
DCF Models
Owner Earnings 0.9800 PLN 4.11 PLN 9.49 PLN 31
5Y Revenue Exit 0.7000 PLN 8.99 PLN 21.15 PLN 39
5Y EBITDA Exit 5.42 PLN 17.00 PLN 32.39 PLN 41
5Y P/E Exit 3.18 PLN 10.22 PLN 38
10Y Revenue Exit 1.32 PLN 8.11 PLN 36
10Y EBITDA Exit 5.84 PLN 14.39 PLN 37
10Y P/E Exit 2.00 PLN 35
Earnings-Based
Graham-Dodd 7.78 PLN 13.18 PLN 16.07 PLN 54
EPV 3.14 PLN 5.04 PLN 6.58 PLN 59
Multiples
P/E Multiple 18.03 PLN 24.04 PLN 30.05 PLN 63
P/S Multiple 14.59 PLN 19.46 PLN 24.32 PLN 58
P/B Multiple 14.59 PLN 19.46 PLN 24.32 PLN 55
EV/EBIT 20.54 PLN 31.63 PLN 42.72 PLN 53
EV/EBITDA 22.94 PLN 34.83 PLN 46.72 PLN 54
EV/Revenue 11.02 PLN 21.19 PLN 31.37 PLN 43
Asset-Based
NCAV (Graham) 5.70 PLN 7.64 PLN 11.41 PLN 50
Growth DCF
Rev-Margin DCF 0.7000 PLN 9.01 PLN 19.14 PLN 74
Economic Profit
Residual Income 9.01 PLN 9.62 PLN 10.60 PLN 61
ROIC Compounder 3.14 PLN 5.04 PLN 6.58 PLN 72
Growth Earnings
Growth-Adj P/E 12.73 PLN 18.18 PLN 23.64 PLN 68

Widest divergence: Multiples (21.19 PLN) versus DCF Models (4.11 PLN). Highest evidence: Rev-Margin DCF (74).

Notify me when HRP reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

P/E ratio 4.4
P/S ratio 0.12 P/E × margin
EPS (TTM) 1.14 PLN price ÷ EPS = P/E 4.4
Net margin 2.9% FY2025
Return on equity -28.0% TTM
Return on assets (EBIT) 3.3% avg 5y
More key figures
Profitability
Operating margin 6.3% TTM
Growth
Revenue (TTM) 237M PLN TTM
Revenue growth (YoY) +7.1% 3y avg -2.5%
EPS growth (YoY) -17.6%
Balance sheet & cash flow
Free cash flow 3.1M PLN FY2025
Net debt 81.0M PLN FY2025 · ≈ 26.1 yrs of FCF

Figures from reported company fundamentals · as of Aug 20, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 51/100

Of which business quality 48 · Market factors (momentum, volatility) 31

Profitability 45
Margins and returns on capital today
Quality Growth 62
Are margins and returns improving?
Cashflow 24
Earnings quality: real cash, not paper profit
Fin. Strength 24
Balance sheet, leverage, solvency risk
Investment 87
Disciplined investing over empire-building
Low Volatility 57
Calm price path (market factor)
Momentum 27
Price trend over the last 3–12 months (market factor)
52W Momentum 9
Distance to the 52-week high (market factor)
Net Issuance 82
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.

About the company

Harper Hygienics S.A. manufactures and sells hygienic products in Poland and internationally. The company offers cotton pads for skin and eyes cleaning and make-up removal, cotton buds, and antibacterial refreshing wet wipes for hands and body; cosmetic buds, intimate hygiene products, and liquids and wipes; disposable wet wipes for infants and children, …

Full company description

Harper Hygienics S.A. manufactures and sells hygienic products in Poland and internationally. The company offers cotton pads for skin and eyes cleaning and make-up removal, cotton buds, and antibacterial refreshing wet wipes for hands and body; cosmetic buds, intimate hygiene products, and liquids and wipes; disposable wet wipes for infants and children, cosmetic pads, and hygienic buds; wipes for surfaces, including as kitchen, bathroom, windows and mirrors, wooden furniture, anti-electrostatic, and leather furniture; and nail varnish removal pads, as well as period pads, pantyliners, dry wipes, under pads, and cotton balls. It offers its products under the Sweet Sense, Cleanic, Cleanic Kindii, Presto Clean, Nieznost, and Ola brand names, as well as private labels for retail chains. Then company was founded in 1990 and is headquartered in Warsaw, Poland. Harper Hygienics S.A. Is a subsidiary of iCotton SIA.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Harper Hygienics S.A. reported revenue of 254M PLN in FY2025 versus 260M PLN in FY2021, a compound −0.6%/yr. Reported net income was 7.3M PLN in FY2025.

Growth Quality 40/100
Revenue growth is weak, negative or inconsistent.
Latest Revenue (FY 2025)
254M PLN
Latest YoY
+11.1%
Avg. revenue growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−2.5%
Avg. revenue growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+1.8%
Avg. revenue growth/yr (16Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+2.4%
Value creation/yr (5Y) Earnings growth per share (CAGR 5 years) plus dividend yield: value created per share and year.
+12.0% (12.0 + 0.0)
Revenue −0.6%/yr
FY21 260M PLN
FY22 275M PLN
FY23 268M PLN
FY24 229M PLN
FY25 254M PLN
Net income
FY21 −10.1M PLN
FY22 437K PLN
FY23 2.7M PLN
FY24 3.2M PLN
FY25 7.3M PLN

Watch HRP: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Harper Hygienics S.A. Fair Value". https://www.fairvalue-calculator.com/stock/HRP

Peer Group

Household & Personal Products · 251 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 51 · Below median
Fair Value upside +88% · Top 25%
Return on assets -2% · Bottom 25%
Net margin (TTM) -7% · Bottom 25%
Operating margin (TTM) 8% · Above median
Revenue growth 4% · Above median
Debt / equity 1.13× · Higher than 75% of peers

Valuation Multiples vs Household & Personal Products median · lower = cheaper

P/E (TTM) 4.4× · Cheaper than 75% of peers
P/B 0.12× · Cheaper than 75% of peers
P/S (TTM) 0.04× · Cheaper than 75% of peers
P/FCF 2.7× · Pricier than median
EV/EBITDA 48.7× · Pricier than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE100 · sector 29
FUTURE19 · sector 8
PAST0 · sector 27
HEALTH44 · sector 98
DIVIDEND0 · sector 52

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Aug 20, 2026).

Stock Price Fair Value vs Fair Value
L'Oréal S.A LORL C$24.76 C$22.64 -9%
Unilever PLC UNA €55.53 €40.47 -27%
Colgate-Palmolive Company CL $90.75 $55.28 -39%
500696 500696 ₹2,093 ₹641.55 -69%
Hindustan Unilever Limited HINDUNILVR ₹2,015 ₹789.46 -61%
Kenvue Inc KVUE $18.98 $10.97 -42%
Kimberly-Clark Corporation KMB $109.55 $79.71 -27%
Henkel AG HEN3 €75.82 €85.95 +13%
The Estée Lauder Companies Inc ESLA €86.54 €18.84 -78%
Church & Dwight Co CHD $101.26 $65.12 -36%

Compare Harper Hygienics S.A. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Discover undervalued stocks

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screener Filter by region, size and sector Compare tool Two stocks side by side Fama-French 3-Factor Model Calculator Run the Fama-French 3-factor model in seconds: expected return from the market, size and value factors - free, with formula, betas and an example. Peter Lynch Fair Value Formula & Calculator Apply Peter Lynch's fair value formula in seconds: fair P/E ≈ earnings growth (+ dividend) - free, with formula and example.

Frequently asked questions

Is Harper Hygienics S.A. (HRP) overvalued or undervalued?
As of Aug 20, 2026, our model estimates a fair value of 9.34 PLN versus a price of 4.97 PLN, about +88% (undervalued).
What is the fair value of HRP?
Our model-based fair value for Harper Hygienics S.A. is 9.34 PLN (as of Aug 20, 2026), built from audited fundamentals. The current price: 4.97 PLN.
What is the quality score of HRP?
Harper Hygienics S.A. has a Quality Score of 51/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Harper Hygienics S.A. (HRP)?
Harper Hygienics S.A. reported trailing-twelve-month revenue of about 237M PLN (latest available figure, as of Aug 20, 2026).
What is the net profit margin of HRP?
The net profit margin of Harper Hygienics S.A. is about -7.4%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

Free · no account needed

Watch Harper Hygienics S.A. in the live analysis

One click puts Harper Hygienics S.A. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.